EMD 52692 (bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes

This publication has 16 references indexed in Scilit:

• Mechanism of myocardial "stunning".
  Circulation, 1990
• Pharmacology and therapeutic effects of nicorandil
  Cardiovascular Drugs and Therapy, 1990
• Effects of nicorandil on coronary circulation and myocardial ischemia
  The American Journal of Cardiology, 1989
• Characterization of a novel K+ channel activator, EMD 52962, in electrophysiological and pharmacological experiments
  Pflügers Archiv - European Journal of Physiology, 1989
• Modulation of voltage-dependent potassium channels in B lymphocytes
  Biochemical Pharmacology, 1988
• The pharmacology of potassium channels and their therapeutic potential
  Trends in Pharmacological Sciences, 1988
• Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog.
  Circulation Research, 1987
• PMN heterogeneity: long-term stability of fluorescent membrane potential responses to the chemoattractant N-formyl-methionyl-leucyl- phenylalanine in healthy adults and correlation with respiratory burst activity
  Blood, 1986
• Ionic Channels in Leukocytes
  Journal of Leukocyte Biology, 1986
• Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils
  Biochemical and Biophysical Research Communications, 1983